Form 4: 908 Devices Director Keith Crandell Reports Equity Transactions, Including RSU Vesting and New Grants

Keith Crandell, a Director and 10% owner of 908 Devices Inc., reported recent equity transactions including the vesting of Restricted Stock Units and the grant of new RSUs and stock options.

Summary

• On June 11, 2025, Keith Crandell settled 11,364 Restricted Stock Units (RSUs), which converted into 11,364 shares of 908 Devices Inc. Common Stock.
• On the same date, the filing also reported a disposition of 25,291 shares of Common Stock.
• On June 12, 2025, Mr. Crandell was granted 14,083 new Restricted Stock Units (RSUs) with a par value of $0.001 per share.
• These newly granted RSUs are scheduled to fully vest on June 12, 2026, or the day prior to the 2026 Annual Meeting of Stockholders, subject to continued service, with prorated vesting if service terminates earlier.
• Also on June 12, 2025, Mr. Crandell received a grant of 6,516 stock options with an exercise price of $7.19 per share and an expiration date of June 11, 2035.
• These stock options will vest in substantially equal monthly installments over 12 months following June 12, 2025, contingent on his continued service.
• Mr. Crandell indirectly beneficially owns 5,725,045 shares through ARCH Venture Fund VII, L.P., and disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 6

Explanation: The document reports routine insider equity transactions, including new grants, which generally indicate continued commitment and alignment of interests. The disposition of shares is ambiguous but could be for common purposes like tax withholding.

Positives

• The continued grant of equity compensation (14,083 RSUs and 6,516 stock options) to a director and significant owner indicates ongoing alignment of interests with shareholders.
• The vesting of 11,364 RSUs demonstrates the realization of previously granted equity compensation.

Negatives

• The reported disposition of 25,291 shares of Common Stock on June 11, 2025, alongside the RSU settlement, results in a net decrease in direct common stock holdings from these specific transactions, the reason for which is not explicitly detailed in the filing.

Future Outlook

The newly granted 14,083 Restricted Stock Units are expected to fully vest on June 12, 2026, or the day prior to the 2026 Annual Meeting of Stockholders, subject to the reporting person's continued service. The 6,516 stock options granted are expected to vest in substantially equal monthly installments over the 12 months following June 12, 2025, contingent on continued service.

Industry Context

This Form 4 filing details routine insider equity transactions for a director and significant shareholder of 908 Devices Inc. It does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• Keith Crandell, as a managing director of ARCH VII LLC (the general partner of ARCH Venture Partners VII, L.P., which is the general partner of ARCH Venture Fund VII, L.P.), is deemed to beneficially own 5,725,045 shares held directly by ARCH Venture Fund VII, L.P. He disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: The new equity grants align the director's interests with shareholders, potentially signaling confidence in the company's future performance. The reported disposition of shares could slightly increase the public float if not for tax purposes.
• Employees: This specific filing primarily concerns director compensation and does not directly impact the broader employee base, though equity compensation is a common practice within the company.

Next Steps

• Continued vesting of 14,083 Restricted Stock Units until June 12, 2026, or the day prior to the 2026 Annual Meeting.
• Continued vesting of 6,516 stock options over the 12 months following June 12, 2025.

Key Dates

Keywords

908 Devices Inc., MASS, SEC Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSU Vesting, Stock Options, Equity Compensation, Director Transactions, ARCH Venture Fund